EPIRUS Biopharmaceuticals, Inc. — Operating Income by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/6ae1ea80-3b30-4be9-8ec1-b9a00cfbd615/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2015 | $-52.3M | 2015-01-01 – 2015-12-31 | evidence 0001558370-16-004428 |
| FY 2014 | $-39.3M | 2014-01-01 – 2014-12-31 | evidence 0001047469-15-002966 |
| FY 2013 | $-14.5M | 2013-01-01 – 2013-12-31 | evidence 0001047469-15-002966 |
| FY 2012 | $-42.8M | 2012-01-01 – 2012-12-31 | evidence 0001193125-13-096030 |
| FY 2011 | $-42.7M | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-106018 |
| FY 2010 | $-7.1M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-106018 |
| FY 2009 | $-20.6M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-106018 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
EPIRUS Biopharmaceuticals, Inc. — all facts · Revenue · Net Income